News related to Actos (Pioglitazone) and/or conditions it is approved for
Avandia Raises Heart Failure Risk More Than Actos
Source: MedicineNet Diabetic Home Care and Monitoring Specialty [2009.08.19]
Title: Avandia Raises Heart Failure Risk More Than Actos
Category: Health News
Created: 8/19/2009 8:10:00 AM
Last Editorial Review: 8/19/2009
Health Tip: The Lactose-Intolerant Diet
Source: MedicineNet Lactose Intolerance Specialty [2009.07.10]
Title: Health Tip: The Lactose-Intolerant Diet
Category: Health News
Created: 7/10/2009 7:00:00 AM
Last Editorial Review: 7/10/2009
Health Tip: Finding Hidden Lactose
Source: MedicineNet Lactose Intolerance Specialty [2009.04.15]
Title: Health Tip: Finding Hidden Lactose
Category: Health News
Created: 4/15/2009 2:00:00 AM
Last Editorial Review: 4/15/2009
Lactose Tolerance Test
Source: MedicineNet Dyspepsia Specialty [2009.04.03]
Title: Lactose Tolerance Test
Category: Procedures and Tests
Created: 11/27/1998 5:08:00 PM
Last Editorial Review: 4/3/2009
Lactose Intolerance
Source: MedicineNet Hydrogen Breath Test Specialty [2008.05.08]
Title: Lactose Intolerance
Category: Diseases and Conditions
Created: 12/14/1998 7:21:00 PM
Last Editorial Review: 5/8/2008
ACTOS shows significant benefits for diabetics
Source: The Doctors Lounge - Endocrinology and Diabetes
A study shows that ACTOS reduces the risk of cardiovascular events by an extra 16% on top of standard medication.
AASLD: NASH Patients Perk Up with Vitamin E (CME/CE)
Source: MedPage Today Gastroenterology [2009.11.06]
BOSTON (MedPage Today) -- Vitamin E and, potentially, pioglitazone (Actos) may become the first effective treatments for nonalcoholic steatohepatitis (NASH), a researcher said here.
|
